Glucose Containing and Glucose Free Hemodialysate in Type 2 Diabetic Patients
NCT ID: NCT02009514
Last Updated: 2020-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
10 participants
INTERVENTIONAL
2002-10-31
2004-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* during the whole hemodialysis day and the whole freeday
* during hemodialysis, during the evening and the night after hemodialysis and at the same time intervals during the freeday in an unselected type 2 diabetic patient group using both glucose-containing and glucose-free dialysate.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continuous Glucose Monitoring in Patients With Diabetes on Peritoneal Dialysis
NCT06069518
Continuous Glucose Monitoring in Dialysis Patients to Overcome Dysglycemia Trial
NCT05509881
Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients
NCT01828970
Continuous Glucose Monitoring in Dialysis Patients With Diabetes
NCT06641765
Improved Glycemic Control in Diabetic Patients in Hemodialysis Using Continuous Glucose Monitoring (CGM)
NCT05678712
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Glucose-containing compared to glucose-free hemodialysate
Comparison of effects on glucose variation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* undergoing stable intermittent thrice weekly hemodialysis for at least one month
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pasi I Nevalainen, MD
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pasi I Nevalainen, MD
Role: PRINCIPAL_INVESTIGATOR
Tampere University Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R02058M
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.